Stay updated on Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.

Latest updates to the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference6%

- Check31 days agoChange DetectedUpdated page version to v3.1.0 and added a contact phone number (502-629-3323); previous version was v3.0.2.SummaryDifference0.1%

- Check45 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.4%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.4%

- Check60 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as various clinical and laboratory techniques related to proteins and antibodies. Notably, previous references to specific types of neoplasms and antineoplastic agents have been removed.SummaryDifference5%

- Check74 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.